BioSig Tech. (BSGM) & Electrophysiology Sector - BioSig Appoints Medical Device Industry Leader to its Board of Directors - James J. Barry, Ph.D. w - BioSig Tech. (BSGM) & Electrophysiology Sector - InvestorVillage


This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: BioSig Tech. (BSGM) & Electrophysiology Sector   /  Message Board  /  Read Message

 
 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  2218 of 2232  at  9/23/2021 1:21:45 PM  by

Rob Cos

The following message was updated on 9/23/2021 5:32:16 PM.

 In response to msg 2215 by  go north
view thread

Re: BioSig Appoints Medical Device Industry Leader to its Board of Directors - James J. Barry, Ph.D. will join as an Independent Director as Company expands clinical footprint with its signal processing tech

Met him at HRS - top quality industry expert. I remember a Boston Scientific Rep at San Fran HRS couple yrs ago...said Boston Sci wanted to partner with BSGM but BSGM wanted to wait. 
 
This guy is a great addition - HRS was simply amazing and the stock price since is simply a head scratcher except to say that the sales and various potentially creative business opportunities to use the analyst Yale Jen phrase after he talked to the company have not happened as fast as some investors hoped into HRS.
 
But today I bought for the first time in awhile. The company with its data sets now and importantly have switched focus from selling need to electrophysiologists have now gone into a full blown different strategy and have started to  provide hospital administrators with more tangible evidence for making purchase decisions.- another analyst comment from report in previous post. Understand electrophysiology and ablations are among the most profitable procedures in the entire hospital arsenal. Imagine a system that makes ablations more efficient, allows Drs to see signals more clearly and get the procedures done more quickly, and helps them see deadly abnormalities the normal cardiac mapping systems do not show.  Its clear - the electrophysiologists see this and want this machine - the advisory board members helping the company switch focus to convincing hospitals why they should buy - think solar companies who sell you on the reduction in your electric bill more than covering the cost of the solar installation - imagine companies realizing this machine will more than pay for itself. That realization was clearly starting to get through at HRS - the 5 HCA reps at the HRS dinner were actually discussing it - they have 180 hospitals. The UPenn and Mayo doctors were not only discussing signals - but the profitability more efficient ablations could bring.  IT was a sea change since the San Francisco HRS talks that were only about signals. 
 
Some will say that report is Laidlaw - blah blah blah - but I sat next to Yale Jen at HRS dinner and my Wells friend and I talked to him outside building as he was leaving as well - he is well versed in when med device companies reach a point where sales and "creative business opportunities come" reach an inflection point and after listening to the Mayo and TCAI Drs praise PURE EP for saving lives, showing signals that would have been missed without it for live saving tachycardia and how they will never go back to ablation without it - he feels BSGM's time is now for sales and Business Development. He loves the prospects over the next 6 months.
 
Also talked to Board Member Sam Navarro at the Boston HRS - he's a deal maker and explained there have been opportunities for partnerships the last 2 yrs that would have helped stock price but it simply was not the time to close those before the data and praise and adoption that is about to happen. That now is the inflection point. Someone else talked to Tony Zook and he felt now through end Q1 will be prime inflection point and news for BSGM stock.
 
Frankly the lack of sales and deals have caused the stock to slip to levels unimaginable to anyone who heard the four Drs and Frank Biden Speak at Boston HRS and saw the data. So you have to ask yourself - are those deals and sales delayed - or not coming like the shorts posted. Is this real technology that works and will provide a boost to high margin ablations to hospitals with vision - or a sham.
 
ITs the former imo - and I think while this rollercoaster the past few yrs partially exasperated by hospitals pandemic inundation and budget cuts -  the next 6 months imo will be that inflection point that many med device companies experience with adoption, sales, data and "creative business opportunities"
 
instead of the absolute bullshit on other boards and stock twits by short trolls paid for by the Canadian short fund that has lied about so many companies and gotten in so much trouble with regulators in the past for those lies and manipulation - listen to the experts - start with Mayo's Dr McLeod HRS presentation (second from top) and keep going and listening to each and everyone of these doctors :
 

Christopher J McLeod MBChB, PhD
Cardiac Electrophysiologist, Mayo Clinic

Source: HRS 2021 - Satellite Discussion July 29, 2021

View it here:
LINK TO PYSICIAN INISGHTS SECTION
 
 
 
 
 
 
 
 
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 10  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
2219 Re: BioSig Appoints Medical Device Industry Leader to its Board of Directors - James J. Barry, Ph.D. will join as an Independent Director as Company expands clinical footprint with its signal processing tech Eatsmelts 7 9/23/2021 6:38:20 PM


Financial Market Data provided by
.
Loading...